Expression of shRNA From a Tissue-specific pol II Promoter Is an Effective and Safe RNAi Therapeutic
Open Access
- 1 September 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (9), 1630-1636
- https://doi.org/10.1038/mt.2008.144
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Tuning silence: conditional systems for RNA interferenceNature Methods, 2006
- Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasisBiochemical and Biophysical Research Communications, 2006
- Molecular Basis for the Recognition of Primary microRNAs by the Drosha-DGCR8 ComplexCell, 2006
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006
- Probing tumor phenotypes using stable and regulated synthetic microRNA precursorsNature Genetics, 2005
- Second-generation shRNA libraries covering the mouse and human genomesNature Genetics, 2005
- Sequence-Specific Inhibition of Small RNA FunctionPLoS Biology, 2004
- Functional siRNAs and miRNAs Exhibit Strand BiasCell, 2003
- Asymmetry in the Assembly of the RNAi Enzyme ComplexCell, 2003
- Formation of the 3′ end of U1 snRNA requires compatible snRNA promoter elementsCell, 1986